The Isotope Production Map, Q4 2026: Preview Report
A free preview of the quarterly map of medical isotope production. It lists every chapter of the 422-page Q4 2026 edition with its page count, all 74 radionuclides it covers, how each capacity figure is recorded on four tiers, one producer row shown field by field, what each of the 17 exhibits shows, and four of this edition's verdicts.
Q4 2026 · Research cut-off: 6 November 2026

What this report answers
- How do I tell announced isotope capacity apart from material that is actually delivered?
- Which major isotopes are expanding, which need watching, and which are structurally concentrated?
- What changed in isotope production between September and November 2026?
- What does a producer table in the full edition record for each producer?
- What does a license to the full edition include?
382 producer rows
Across 284 organizations and 74 radionuclides with named producers, in the full Q4 2026 edition.
97 countries
Covered in the full edition, with named producers in 50 and cyclotron counts by country for 96.
What the analysis establishes
Four tiers for every figure
Every capacity figure in the map sits on one of four tiers: announced, commissioned, GMP or national approval, and actual output. An announced figure is never treated as output. A tier with no public figure carries an open circle, and a figure that is the operator's own statement carries a dagger, so a reader can see at a glance how much of a stated capacity rests on the record.
Verdicts for buyers
Each edition gives a verdict for each major isotope. The preview shows four of this edition's verdicts. The facts that carry them, and the remaining verdicts, are in the full edition.
What changed this quarter
A selection of the dated developments between 1 September and 6 November 2026, covering reactors, Ac-225, Lu-177 and ownership. The full edition dates each one and names the organizations involved.
One producer row, in full
All 382 producer rows take the same form. The preview shows one, a university research cyclotron group, field by field as the edition records it: every tier, every figure with its date, and whose statement each figure is.
The edition, chapter by chapter
Every chapter of the full edition with its page count and the number of producer rows in its tables, the full list of radionuclides and enriched target isotopes covered, and what each of the 17 exhibits shows, at what scale.
About this intelligence
Sources include public registries, regulator records, company filings and disclosures. Other sources are proprietary ProGen intelligence sources. Facts are linked to their sources and dated; interpretation is labeled "ProGen reading". A figure reported only by a third party may appear in a table, but never feeds totals, rankings, charts or the executive summary.
Investors and corporate development teams sizing the supply risk behind a pipeline or a deal. Radiopharmaceutical developers qualifying a second source. Isotope producers and CDMOs reading the competitive field. Business development teams selling equipment, targets and services into isotope producers.
Contents
- Why a map of isotope production
- What the full edition holds
- The edition, chapter by chapter
- The 74 radionuclides
- How every figure is recorded
- One producer row, in full
- The 17 exhibits
- The verdicts for buyers
- What changed, 1 September to 6 November 2026
- What a license includes
Isotopes with full profiles in the edition
Mo-99/Tc-99m, Lu-177, Tb-161, Gd-160, Ac-225, Pb-212, Th-228
The full 7-page briefing is free. Tell us where to send it and it downloads immediately.
The Isotope Production Map
Built to your question and quoted individually: every producer, route and capacity tier in medical isotope supply, refreshed quarterly.
See the analysis →